MCID: VSL003
MIFTS: 40

Visual Agnosia

Categories: Mental diseases, Eye diseases

Aliases & Classifications for Visual Agnosia

MalaCards integrated aliases for Visual Agnosia:

Name: Visual Agnosia 12 15
Primary Visual Agnosia 44 73

Classifications:



External Ids:

Disease Ontology 12 DOID:0060155
MeSH 44 C531604
UMLS 73 C2930796

Summaries for Visual Agnosia

Disease Ontology : 12 An agnosia that is a loss of the ability to visually recognize objects.

MalaCards based summary : Visual Agnosia, also known as primary visual agnosia, is related to prosopagnosia and alexia. An important gene associated with Visual Agnosia is PSEN1 (Presenilin 1), and among its related pathways/superpathways are Neuroscience and Wnt / Hedgehog / Notch. The drugs Lidocaine and Nalbuphine have been mentioned in the context of this disorder. Affiliated tissues include brain, cortex and temporal lobe.

Wikipedia : 76 Visual agnosia is an impairment in recognition of visually presented objects. It is not due to a deficit... more...

Related Diseases for Visual Agnosia

Diseases related to Visual Agnosia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 67)
# Related Disease Score Top Affiliating Genes
1 prosopagnosia 31.3 GRN PSEN1
2 alexia 30.9 KANTR PSEN1
3 agnosia 12.0
4 kluver-bucy syndrome 10.9
5 alzheimer disease 4 10.8 PSEN1 PSEN2
6 early-onset, autosomal dominant alzheimer disease 10.8 PSEN1 PSEN2
7 phonagnosia 10.8 GRN PSEN1
8 familial idiopathic basal ganglia calcification 10.8 PSEN1 PSEN2
9 associative agnosia 10.8 GRN PSEN1
10 progressive non-fluent aphasia 10.8 GRN PSEN1
11 behavioral variant of frontotemporal dementia 10.8 GRN PSEN1
12 writing disorder 10.8 GRN PSEN1
13 gait apraxia 10.8 GRN PSEN1
14 semantic dementia 10.7 GRN PSEN1
15 echolalia 10.7 GRN PSEN1
16 early-onset familial alzheimer disease 10.7 PSEN1 PSEN2
17 mesenteric vascular occlusion 10.6 F7 MB
18 ideomotor apraxia 10.5 GRN PSEN1
19 alzheimer disease 2 10.5 PSEN1 PSEN2
20 glossopharyngeal neuralgia 10.5 KANTR NUMA1
21 angiomyoma 10.5 MB SYP
22 apperceptive agnosia 10.5 PSEN1 TOR3A
23 facial hemiatrophy 10.4 KANTR SLC4A1
24 internuclear ophthalmoplegia 10.4 KANTR PSEN1
25 substernal goiter 10.4 F7 KANTR
26 mixed cell type cancer 10.4 MB SYP
27 immune system organ benign neoplasm 10.4 MB SYP
28 thymus lipoma 10.4 MB SYP
29 frontotemporal dementia 10.4 GRN PSEN1 PSEN2
30 anterior cranial fossa meningioma 10.4 F7 KANTR
31 myxosarcoma 10.4 MB SYP
32 nominal aphasia 10.3 GRN PSEN1
33 posterior myocardial infarction 10.3 KANTR MB
34 subendocardial myocardial infarction 10.3 KANTR MB
35 transient global amnesia 10.3 KANTR PSEN1
36 postencephalitic parkinson disease 10.3 KANTR SYP
37 punctate epithelial keratoconjunctivitis 10.3 KANTR PSEN2
38 radiation cystitis 10.3 F7 KANTR
39 medullomyoblastoma 10.3 MB SYP
40 intraocular retinoblastoma 10.3 KANTR SYP
41 functional colonic disease 10.2 KANTR SYP
42 cardiovascular organ benign neoplasm 10.2 KANTR MB
43 agraphia 10.2 GRN KANTR PSEN1
44 cerebellopontine angle tumor 10.2 KANTR SYP
45 benign perivascular tumor 10.1 KANTR MB
46 disease of mental health 10.1 GRN PSEN1 TOR3A
47 pseudohyperkalemia, familial, 2, due to red cell leak 10.0 MB SLC4A1
48 alzheimer disease 10.0
49 colonic pseudo-obstruction 10.0 KANTR SYP
50 autism 9.9

Graphical network of the top 20 diseases related to Visual Agnosia:



Diseases related to Visual Agnosia

Symptoms & Phenotypes for Visual Agnosia

Drugs & Therapeutics for Visual Agnosia

Drugs for Visual Agnosia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 113)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 137-58-6 3676
2
Nalbuphine Approved Phase 4 20594-83-6 5360630 5311304
3
Bupivacaine Approved, Investigational Phase 4,Not Applicable 2180-92-9, 38396-39-3 2474
4
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
5
Morphine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 57-27-2 5288826
6
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Not Applicable 50-02-2 5743
7
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Not Applicable 103-90-2 1983
8
Levobupivacaine Approved, Investigational Phase 4,Not Applicable 27262-47-1 92253
9
Clonidine Approved Phase 4 4205-90-7 2803
10
Tramadol Approved, Investigational Phase 4,Phase 3 27203-92-5 33741
11
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
12
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 68602 5311068
13
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
14
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
15
Ropivacaine Approved Phase 4,Phase 3,Not Applicable 84057-95-4 71273 175805
16
Ibuprofen Approved Phase 4,Not Applicable 15687-27-1 3672
17
Sufentanil Approved, Investigational Phase 4,Not Applicable 56030-54-7 41693
18
gamma-Aminobutyric acid Approved, Investigational Phase 4 56-12-2 119
19
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
20
Dezocine Approved, Investigational Phase 4 53648-55-8 40841 3033053
21
Remifentanil Approved Phase 4,Phase 3,Not Applicable 132875-61-7 60815
22
Ketoprofen Approved, Vet_approved Phase 4 22071-15-4 3825
23
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
24 Nefopam Approved, Investigational Phase 4 13669-70-0
25 Dexamethasone acetate Phase 4,Not Applicable 1177-87-3
26 Analgesics Phase 4,Phase 2,Phase 3,Not Applicable
27 glucocorticoids Phase 4,Not Applicable
28
protease inhibitors Phase 4,Not Applicable
29 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
30 Adjuvants, Anesthesia Phase 4,Phase 3,Not Applicable
31 Gastrointestinal Agents Phase 4,Not Applicable
32 Narcotics Phase 4,Phase 2,Phase 3,Not Applicable
33 Sodium Channel Blockers Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
34 Neurotransmitter Agents Phase 4,Not Applicable
35 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Not Applicable
36 Analgesics, Opioid Phase 4,Phase 2,Phase 3,Not Applicable
37 HIV Protease Inhibitors Phase 4,Not Applicable
38 Anesthetics Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
39 Anesthetics, Dissociative Phase 4
40 Hormone Antagonists Phase 4,Not Applicable
41 Anesthetics, General Phase 4,Phase 3,Not Applicable
42 Anesthetics, Intravenous Phase 4,Phase 3,Not Applicable
43 Anesthetics, Local Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
44 Hormones Phase 4,Not Applicable
45 Diuretics, Potassium Sparing Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
46 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Not Applicable
47 Anti-Arrhythmia Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
48 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
49 Excitatory Amino Acid Antagonists Phase 4,Not Applicable
50 Excitatory Amino Acids Phase 4,Not Applicable

Interventional clinical trials:

(show top 50) (show all 65)
# Name Status NCT ID Phase Drugs
1 Ketamine and Postoperative Analgesia in Children Unknown status NCT00200564 Phase 4 ketamine
2 Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks Completed NCT02523235 Phase 4 ropivacaine 0.2%
3 The Combination Effect of Dexmedetomidine and Morphine in Postoperative Patient-Controlled Analgesia Completed NCT00800826 Phase 4 dexmedetomidine
4 Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia Completed NCT02516059 Phase 4 oxycodone/naloxone;Oxycodone;Placebo
5 Multimodal Analgesic Treatment Versus Traditional Morphine Analgesia After Cardiac Surgery Completed NCT01966172 Phase 4 Ibuprofen;Gabapentin;Morphine;Paracetamol
6 Postoperative Pain and SIRS After Preoperative Analgesia With Clonidine or Levobupivacaine Completed NCT00860899 Phase 4 clonidine, levobupivacaine
7 Continuous Infusion of Dexamethasone Plus Tramadol Adjunct to Morphine PCA After Abdominal Hysterectomy Completed NCT00564603 Phase 4 Dexamethasone Sodium Phosphate Injection
8 Effect of Dexmedetomidine for Postoperative Intravenous Patient Controlled Analgesia Recruiting NCT03014713 Phase 4 Dezocine;Flubiprofen;Dexmedetomidine
9 Dexmedetomidine Supplemented Analgesia and 2-Year Survival After Cancer Surgery Recruiting NCT03012971 Phase 4 Dexmedetomidine supplemented morphine analgesia;Morphine analgesia
10 Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium Recruiting NCT03012984 Phase 4 Dexmedetomidine supplemented morphine analgesia;Morphine analgesia
11 Intravenous and Intraperitoneal Lignocaine for Perioperative Analgesia in Laparoscopic Colon Resections Not yet recruiting NCT03105193 Phase 4 IV Saline bolus and infusion;IP Saline bolus and infusion;IV lignocaine bolus and infusion;IP Lignocaine bolus and infusion
12 Intrathecal Morphine Analgesia vs. Continuous Epidural Analgesia vs. Systemic Analgesia in Colorectal Surgery. Not yet recruiting NCT03007121 Phase 4 Morphine intrathecal;Bupivacaine + Sufentanil epidural;Morphine intravenous
13 Non-opioid Analgesic Combination With Morphine for Postoperative Analgesia. Terminated NCT01882530 Phase 4 Paracetamol;Nefopam;Ketoprofen;Morphine
14 A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation. Terminated NCT00421720 Phase 4 Sufentanil;Remifentanil
15 A PhaseⅡ/ Ⅲ Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-based Postoperative Analgesia Unknown status NCT02811991 Phase 2, Phase 3 Paracetamol injection;Normal Saline injection;Morhpine PCA
16 Combination Analgesia for Neonatal Circumcision Completed NCT02990364 Phase 3 Sucrose;Lidocaine;EMLA Topical Product
17 Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia Completed NCT02264821 Phase 3 ropivacaine infiltration;intrathecal morphine;placebo
18 Tramadol Versus Fentanyl for Post-Operative Analgesia in Newborn Infants Completed NCT00713726 Phase 3 FentanyL;Tramadol
19 Continuous Regional Analgesia After Total Knee Arthroplasty Completed NCT00337597 Phase 3
20 Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU) Terminated NCT00436345 Phase 3 Remifentanil;Propofol
21 Development of a New Method for Analgesia Completed NCT00791024 Phase 1, Phase 2 CRC-Pharma 001;lidocaine suspension
22 Dexamethasone Added to Levobupivacaine Improves Postoperative Analgesia Unknown status NCT01739270 Not Applicable
23 Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients Unknown status NCT01553435 Not Applicable Dextromethorphan;Placebo
24 Do Epidurals Placed at a Lower Level Improve Labor Analgesia? Unknown status NCT00954317 Not Applicable
25 Depodur vs Fentanyl Infusion for Post-C/S Analgesia Unknown status NCT00762554 Not Applicable Depodur;Depodur;Fentanyl
26 Low Level Laser (LED) Use to Increase Dental Implant Stability and Post Operative Analgesia Unknown status NCT01097499 Not Applicable
27 Effect of Thoracic Epidural Analgesia for Thoracotomy on the Occurrence of AF Unknown status NCT01718717 Not Applicable
28 Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population. Unknown status NCT01817101 Not Applicable
29 Perception and Multisensory Integration in Neurological Patients Using fMRI Unknown status NCT01469858 Not Applicable
30 Orientation Agnosia: Clinical and Anatomical Study Completed NCT01304576 Not Applicable
31 Newborn Cortical Response to Pain and Non Pharmacological Analgesia Completed NCT03389789 Not Applicable
32 Comparison of Patient-Controlled Analgesia With Different Background Infusion Completed NCT03221491 Not Applicable
33 Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty Completed NCT03203967 Not Applicable Intravenous morphine analgesia
34 Individualized Analgesia on Respiratory Adverse Events After Adenotonsillectomy Completed NCT02990910 Not Applicable personalized opioid analgesia
35 A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Local Infiltration Analgesia for Postoperative Analgesia After Total Knee Arthroplasty Completed NCT02104934 Not Applicable
36 μ-opioid Receptor Polymorphism and Opioid Analgesia Completed NCT02099877 Fentanyl
37 The Effect of Oxytocin on Placebo Analgesia: an Experimental Study in Healthy Volunteers Completed NCT01886014 Not Applicable Oxytocin
38 Labour Analgesia and Movement in Babies Completed NCT01280084
39 The Randomised Epidural Analgesia in Term Delivering Women Trial (TREAT) Completed NCT01261689 Not Applicable Ropivacaine/ Sufentanil according to local hospital protocol
40 Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia Completed NCT00487084 Not Applicable Morphine-CP-saline (MCS);saline-2CP-morphine (SCM);saline-lidocaine-morphine (SLM)
41 Individualized Timing of Analgesia and Effectiveness of Labor Analgesia Completed NCT02920489 Not Applicable Individualized epidural analgesia;Routine epidural analgesia
42 Epidural Analgesia in Intensive Care Unit (APD-REA: Analgesie PeriDurale en REAnimation) Completed NCT01437358
43 Effects of Thoracic Epidural Analgesia and Surgery on Lower Urinary Tract Function: A Randomized, Controlled Study Completed NCT01220362 Not Applicable Bupivacain 0.125%;Bupivacain 0.125%/Fentanyl 2mcg/ml
44 Surgical Stress Index as a Tool for Monitoring Analgesia and/or Sedation in Critically Ill Patients Completed NCT00789412
45 Telemedically Supported Analgesia in the Emergency Medical Service Completed NCT01644032 Not Applicable
46 Monitor-Guided Analgesia During General Anesthesia - Part I Completed NCT03303651 Not Applicable
47 Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Completed NCT00908999
48 Neuraxial Labor Analgesia and the Incidence of Postpartum Depression Completed NCT02823418
49 TAP vs Caudal Block Using Dexmedetomidine/ Bupivacaine for Post Operative Analgesia Recruiting NCT03482947 Not Applicable ultrasonography-guided TAP block;Caudal epidural block
50 Perfusion Index and Labor Analgesia Recruiting NCT03107559

Search NIH Clinical Center for Visual Agnosia

Cochrane evidence based reviews: primary visual agnosia

Genetic Tests for Visual Agnosia

Anatomical Context for Visual Agnosia

MalaCards organs/tissues related to Visual Agnosia:

41
Brain, Cortex, Temporal Lobe, Colon, Eye

Publications for Visual Agnosia

Articles related to Visual Agnosia:

(show top 50) (show all 114)
# Title Authors Year
1
The neuropsychological rehabilitation of visual agnosia and Balint's syndrome. ( 29366371 )
2018
2
The contribution of facial dynamics to subtle expression recognition in typical viewers and developmental visual agnosia. ( 29723598 )
2018
3
Visual agnosia and focal brain injury. ( 28843416 )
2017
4
Preserved Expert Object Recognition in a Case of Unilateral Visual Agnosia. ( 28949822 )
2017
5
Pearls & Oy-sters: Visual agnosia: An overlooked cortical sign. ( 27821572 )
2016
6
Visual agnosia. ( 26358494 )
2015
7
Making memories: the development of long-term visual knowledge in children with visual agnosia. ( 24319599 )
2013
8
Configural Gestalts remain nothing more than the sum of their parts in visual agnosia. ( 25165506 )
2013
9
The right place at the right time: priming facial expressions with emotional face components in developmental visual agnosia. ( 22349446 )
2012
10
Selective impairment of living things and musical instruments on a verbal 'Semantic Knowledge Questionnaire' in a case of apperceptive visual agnosia. ( 22771855 )
2012
11
Eye movements during object recognition in visual agnosia. ( 22627025 )
2012
12
Visual agnosia and posterior cerebral artery infarcts: an anatomical-clinical study. ( 22276198 )
2012
13
Visual agnosia. ( 23144207 )
2012
14
Perception of biological motion in visual agnosia. ( 22973210 )
2012
15
Impaired integration of emotional faces and affective body context in a rare case of developmental visual agnosia. ( 21482423 )
2012
16
Psychic blindness or visual agnosia: early descriptions of a nervous disorder. ( 21253940 )
2011
17
Modeling eye movements in visual agnosia with a saliency map approach: bottom-up guidance or top-down strategy? ( 21316191 )
2011
18
Development of a vocabulary of object shapes in a child with a very-early-acquired visual agnosia: a unique case. ( 20680887 )
2011
19
Separate processing of texture and form in the ventral stream: evidence from FMRI and visual agnosia. ( 19478035 )
2010
20
Visual agnosia for line drawings and silhouettes without apparent impairment of real-object recognition: a case report. ( 19996516 )
2009
21
The neuropsychological and neuroradiological correlates of slowly progressive visual agnosia. ( 19184324 )
2009
22
Fixation and saliency during search of natural scenes: the case of visual agnosia. ( 19428433 )
2009
23
To know what it is for, but not how it is: semantic dissociations in a case of visual agnosia. ( 18704832 )
2008
24
Associative visual agnosia: a case study. ( 18413915 )
2008
25
Chapter 21 Visual agnosia. ( 18631704 )
2008
26
Implicit integration in a case of integrative visual agnosia. ( 17339044 )
2007
27
Impairments in part-whole representations of objects in two cases of integrative visual agnosia. ( 18066732 )
2007
28
[Apperceptive form visual agnosia caused by anti-TNFalpha therapy to rheumatoid arthritis]. ( 17511276 )
2007
29
No double-dissociation between optic ataxia and visual agnosia: multiple sub-streams for multiple visuo-manual integrations. ( 16753188 )
2006
30
A two-stage account of computing and binding occluded and visible contours: Evidence from visual agnosia and effects of lorazepam. ( 21049331 )
2006
31
The role of sensory-motor information in object recognition: evidence from category-specific visual agnosia. ( 15896389 )
2005
32
Behavioral change and its neural correlates in visual agnosia after expertise training. ( 15829077 )
2005
33
Visuomotor performance in a patient with visual agnosia due to an early lesion. ( 15130585 )
2004
34
2D but not 3D: pictorial-depth deficits in a case of visual agnosia. ( 15505981 )
2004
35
Electrophysiological correlates of associative visual agnosia lesioned in the ventral pathway. ( 15178214 )
2004
36
Radical "visual capture" observed in a patient with severe visual agnosia. ( 12719638 )
2003
37
Category-specific visual agnosia: lesion to semantic memory versus extra-lesional variables in a case study and a connectionist model. ( 14642293 )
2003
38
Visual agnosia. ( 12916489 )
2003
39
What does visual agnosia tell us about perceptual organization and its relationship to object perception? ( 12669745 )
2003
40
Visual agnosia in a child with non-lesional occipito-temporal CSWS. ( 12767457 )
2003
41
Implicit face perception in a patient with visual agnosia? Evidence from behavioural and eye-tracking analyses. ( 12591027 )
2003
42
Visual agnosia. ( 14565906 )
2003
43
A Case Study of Visual Agnosia without Perceptual Processing or Structural Descriptions Impairment. ( 20957586 )
2003
44
Visual agnosia and prosopagnosia in childhood: a prospective case study. ( 12610772 )
2002
45
The role of premorbid expertise on object identification in a patient with category-specific visual agnosia. ( 20957546 )
2002
46
Visual agnosia after treatment of a posterior fossa ependymoma in a 16-month-old girl. ( 11575616 )
2001
47
Visual agnosia and KlA1ver-Bucy syndrome in marmosets (Callithrix jacchus) following ablation of inferotemporal cortex, with additional mnemonic effects of immunotoxic lesions of cholinergic projections to medial temporal areas. ( 11292457 )
2001
48
Animals and artifacts may not be treated equally: differentiating strong and weak forms of category-specific visual agnosia. ( 11237370 )
2001
49
Early onset epileptic auditory and visual agnosia with spontaneous recovery associated with Tourette's syndrome. ( 11561053 )
2001
50
The computation of occluded contours in visual agnosia: Evidence for early computation prior to shape binding and figure-ground coding. ( 20945203 )
2000

Variations for Visual Agnosia

Expression for Visual Agnosia

Search GEO for disease gene expression data for Visual Agnosia.

Pathways for Visual Agnosia

Pathways related to Visual Agnosia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.79 PSEN1 PSEN2 SLC4A1 SYP
2 11.76 CYLD PSEN1 PSEN2
3 10.69 PSEN1 PSEN2
4 10.52 PSEN1 PSEN2
5 9.32 PSEN1 PSEN2

GO Terms for Visual Agnosia

Cellular components related to Visual Agnosia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 centrosome GO:0005813 9.62 CYLD NUMA1 PSEN1 PSEN2
2 cell cortex GO:0005938 9.43 NUMA1 PSEN1 PSEN2
3 dendritic shaft GO:0043198 9.37 PSEN1 PSEN2
4 Z disc GO:0030018 9.33 PSEN1 PSEN2 SLC4A1
5 ciliary rootlet GO:0035253 8.96 PSEN1 PSEN2
6 neuromuscular junction GO:0031594 8.8 PSEN1 PSEN2 SYP

Biological processes related to Visual Agnosia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 proteolysis GO:0006508 9.77 CYLD ENSG00000264813 F7 PSEN1 PSEN2
2 response to hypoxia GO:0001666 9.65 F7 MB PSEN2
3 membrane protein ectodomain proteolysis GO:0006509 9.46 PSEN1 PSEN2
4 regulation of protein binding GO:0043393 9.43 CYLD PSEN1
5 membrane protein intracellular domain proteolysis GO:0031293 9.4 PSEN1 PSEN2
6 Notch receptor processing GO:0007220 9.32 PSEN1 PSEN2
7 amyloid-beta metabolic process GO:0050435 9.26 PSEN1 PSEN2
8 Notch receptor processing, ligand-dependent GO:0035333 9.16 PSEN1 PSEN2
9 amyloid precursor protein catabolic process GO:0042987 8.96 PSEN1 PSEN2
10 protein processing GO:0016485 8.8 F7 PSEN1 PSEN2

Molecular functions related to Visual Agnosia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptidase activity GO:0008233 9.35 CYLD ENSG00000264813 F7 PSEN1 PSEN2
2 endopeptidase activity GO:0004175 9.33 F7 PSEN1 PSEN2
3 aspartic-type endopeptidase activity GO:0004190 9.26 PSEN1 PSEN2
4 aspartic endopeptidase activity, intramembrane cleaving GO:0042500 8.62 PSEN1 PSEN2

Sources for Visual Agnosia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....